News About CV Outcomes, Inc.

  • KCCQ Approved by FDA for Regulatory Submissions for Heart Failure Drugs

    Following up its prior approval of the KCCQ as a primary endpoint for labeling claims for heart failure devices, the FDA has also approved the KCCQ as a primary endpoint for heart failure medications.

    ...Read more

  • CVO Web Site Improvements

    After a long development and testing process, we proudly unveil the new CVO web site. It represents a fundamental rewriting of the code involving a number of enhancements.

    ...Read more

  • KCCQ Approved by FDA for Regulatory Submissions for Heart Failure Medical Devices

    In a crucial endorsement of the validity and reliability the KCCQ, the US Food and Drug Administration has qualified the KCCQ to be used by medical device companies to support regulatory submissions for heart failure medical devices. Sponsor/investigators may use KCCQ data to establish safety and effectiveness of such devices. As detailed in the FDA annoucement, KCCQ scale scores “can be used as a component of a composite primary endpoint or secondary endpoint in a feasibility or pivotal clinical trial evaluating heart failure medical devices. The instrument can be used in superiority and non-inferiority trials evaluating out­ patients or in-patients with heart failure syndrome. For in-patient studies, post-discharge outcomes could be helpful to define the health status benefits of treatment.”

    ...Read more

  • CV Outcomes Web Site Updated

    We have just updated and improved our web site. In addition to obvious cosmetic changes to the user interface, we have simplified and focused the information design. We hope that this makes it easier for visitors to the public portions of the site to find the information they need quickly.

    ...Read more

  • Shortened Version of SAQ Now Available

    On September 2, 2014, Circulation: Cardiovascular Quality and Outcomes published the development of the 7-item SAQ. This shortened version of the SAQ reduces the scale from 19 to 7 items. While it does not collect the Angina Stability or Treatment Satisfaction scale, it produces extremely valid, reliable and sensitive measures of the Angina Frequency, Physical Limitation and Quality of Life domains, along with a new Summary Score. While some studies may prefer the additional domains in the full version, the shortened version markedly decreases respondent burden and is more practical for routine clinical care – a key direction for patient-reported outcomes measures, as cited in an accompanying editorial.

  • New CV Outcomes Web Site Now Up and Running

    You have reached our new, upgraded web site for CV Outcomes. We hope you find the changes to be beneficial.

    ...Read more

  • New CVO Site Arrives This Sunday 21 September

    This weekend we’re moving the CVO web site to a new system and web hosting setting. Re-engineered from the ground up, our new technologies should provide some significant benefits and a better user interface. The move will cause two important points of disruption, however:

    ...Read more

  • ISP infrastructure Revision Now Complete

    Update: Our conversion to a new fiber-optic network is now complete. You should see some improvement in operations. We apologize again for any inconvenience during the change-over.

  • Credit Card Payment Now Available Option for Instrument Licenses

    We now are able to accept payment by credit card for licenses to use the SAQ, KCCQ, and PAQ plus related calculation tools. Every new invoice generated from now on will contain instructions about payment options including credit card payments.

    ...Read more

  • CVO and CORC Lead the D2B Alliance

    CVO and CORC investigators are leading efforts to reduce door to balloon times through the D2B Alliance. The D2B Alliance is a national campaign of the American College of Cardiology in collaboration with the American Heart Association, the National Heart, Lung and Blood Institute, and 33 other organizations.

    ...Read more

  • KCCQ, SAQ, and PAQ Calculators Upgraded to Support Patient Results Graphing

    To assist deployment of the Kansas City Cardiomyopathy Questionnaire, the Seattle Angina Questionnaire, and the Peripheral Artery Questionnaire into clinical settings, the KCCQ Calculator, SAQ Calculator, and PAQ Calculator now can extract and graph individual patient scale scores. “At the point of care, seeing a graphical trend over time of a patients functional status can be an important factor when making therapeutic decisions,” says John Spertus, MPH MD, author of the KCCQ, SAQ, and PAQ. “The upgraded Calculators makes this easy.” Further details — including screenshots — are available here.

    ...Read more

  • Turkish Versions of KCCQ and SAQ Now Available

    Drs. John Spertus and Tuncay Duruoz have collaborated to produce Turkish versions of the Kansas City Cardiomyopathy Questionnaire and the Seattle Angina Questionnaire, which are now available. “Dr. Duruoz, a rheumatologist and physiatrist at the Celal Bayar University Medical School, was instrumental in translating these instruments into Turkish,” states Dr. Spertus.

    ...Read more

  • CORC Collaborators in NHLBI Working Group Issue Outcomes Research Report

    The National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease, co-chaired by Cardiovascular Outcomes Research Consortium members Harlan Krumholz and Eric Peterson and staffed by a number of other CORC colleagues, has just published its report in Circulation. The report is available for download here.

    ...Read more

  • Krumholz Publishes "The Expert Guide to Beating Heart Disease"

    Harlan Krumholz MD SM, esteemed member of the Cardiovascular Outcomes
    Research Consortium
    and Professor of Medicine and Epidemiology and
    Public Health at Yale University School of Medicine, has just published
    a new patient-oriented book called The Expert Guide to Beating Heart Disease: What You Absolutely Must Know. “Harlan’s book beautifully describes the clinical applications of the sorts of outcomes research we do at CORC,” says John Spertus MD MPH, director of CORC. “His introduction to the Seattle Angina Questionnaire is particularly useful.”

    ...Read more

  • Peripheral Artery Questionnaire Released

    CV Outcomes is pleased to provide licensing opportunities for the Peripheral Artery Questionnaire. The PAQ is a disease-specific health status measure for patients with peripheral arterial disease. Like the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire, the PAQ has been rigorously tested to demonstrate its validity, reliability and responsiveness. For a disease such as peripheral arterial disease, in which the primary goal of treatment is to improve patients’ symptoms, function and quality of life, it is hoped that the PAQ can serve as a primary endpoint in clinical trials, as a marker of severely affected patients requiring treatment and as a tool for improving the quality and follow-up of treated patients.

    ...Read more

  • Clinical Trials / Clinical Research Expo at Medinfo

    The Epimetrics Group will showcase the CV Outcomes web site and its collaborative tools for academic research networks at the Clinical Trials / Clinical Research Expo at medInfo 2004. This session is sponsored by the AMIA Clinical Trials Working Group and will include a wide range of developers and users:

    • National Cancer Institute
    • University of Louisville
    • University of California, San Francisco
    • MedDak
    • City of Hope
    • Thomas Jefferson University
    • Intermountain Health Care
    • Merck & Company
    • Yale University
    • National Library of Medicine
    • The Epimetrics Group
    • The University of Washington
    • Johns Hopkins University
    • Datamedica

    ...Read more

  • Upgraded Server Now Functioning

    After suffering a hard drive crash a week ago and hobbling along on a backup server in the interim, we’re now back in business with an upgraded server box. We think that all functions are running fine and that you should notice substantially improved performance. Please let us know if you encounter any problems, errors or other issues. Thanks!

  • Mid America Heart Institute Receives Multi-Million Dollar Research Grant

    The National Institutes of Health has awarded Saint Luke’s Mid America Heart Institute in Kansas City and Washington University in St. Louis over $15 million in a Specialized Center for Clinically Oriented Research (SCCOR) grant to fund a five-year, multi-center study of patients recovering from heart attacks.

    ...Read more

  • New KCCQ Section

    We’ve begun an informative series of articles about the Kansas City Cardiomyopathy Questionnaire here. Check this section out for information about the reliability, responsiveness and interpretability of the KCCQ, among other topics.

    ...Read more

  • Licensing Instruments at CV Outcomes

    Through our online registration system, you can license and download our HRQOL instruments – currently the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire. You can also license and download tools that calculate the instruments’ scale scores from patient responses.

    ...Read more

  • Department of Defense Study

    CV Outcomes has collaborated with Yale University to design and conduct a randomized controlled trial examining the impact of implementing decision support tools at two military treatment facilities.

    ...Read more

  • CORC and Wash U reach Reynolds Finals

    An application to the Donald W.Reynolds Foundation to support a $24 million dollar Translational Research Grant from Washington University and the Mid America Heart Institute is selected as one of 4 finalist from an initial pool of 27 applicants from among the finest cardioavscular research insitutions in the country. Designed to advance the fight against cardiovascular disease and diabetes, the centerpiece of this innovative translational research effort is an ongoing post-MI registry by the Cardiovascular Outcomes Research Consortium (CORC).

  • PREMIER QI Registry Nears 1000 Subject Enrollment Milestone!

    Enrollment in the PREMIER QI Registry is proceeding apace.

    ...Read more

  • New Online Source for Instruments and Tools!

    Through our new online registration system, you can now license and download our HRQOL instruments – currently the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire. You can also license and download tools that calculate the instruments’ scale scores from patient responses.

    ...Read more

  • American Heart Association Participates in PREMIER

    CORC is very excited to announce a new participant in the PREMIER QI Registry; the American Heart Association (AHA).

    ...Read more

  • CV Outcomes Launches National Post-MI Registry - The PREMIER QI Registry

    CV Outcomes, with generous support from CV Therapeutics, is launching a multi-center post-MI registry to define the prevalence, determinants and consequences of post-MI angina and to advance the methods for quantifying the quality of MI care.

    ...Read more

  • Seattle Angina Questionnaire and Kansas City Cardiomyopathy Questionnaire Demos Now Available

    Interactive demo versions of the Seattle Angina Questionnaire and Kansas City Cardiomyopathy Questionnaire can now be accessed in the Instruments section of the CVOutcomes site.

    ...Read more

  • CV Outcomes to Partner with ACC on HF GAP Program

    CV Outcomes has enthusiastically agreed to serve as an official partner to the American College of Cardiology (ACC) in its Guidelines Applied in Practice (GAP) Program. The ACC developed its GAP programs in an effort to improve the quality of cardiovascular care by bringing ACC/AHA practice guidelines to the point of patient care. The program consists of a series of projects to develop and test tools and strategies for implementing guidelines. Key features of GAP projects are the building of partnerships, flexibility for local adaptation of tools derived from guidelines, involvement of caregivers across the continuum of care (i.e., not just cardiologists), involvement of patients, use of champions/opinion leaders, and use of data to change behavior and measure effectiveness of the approach.

    ...Read more

  • CORC Meeting at ACC 2002 in Atlanta

    The international team of CORC investigators met in Atlanta on Sunday, March 17th.

  • CV Outcomes Launches Web Site in Partnership with The Epimetrics Group

    To empower its Cardiovascular Outcomes Research Consortium, CV Outcomes, Inc. has engaged The Epimetrics Group to create and host a variety of collaborative information tools at this web site.

    ...Read more